> Japanese
Dates: 14 May [Wed] - 16 [Fri], 2014
Venue: Tokyo Big Sight
Organised by: Reed Exhibitions Japan, Ltd.
FREEACADEMIC FORUM
At Academic Forum, researchers of universities and
national/public institutes will present their latest research results
through Oral Presentation and Poster Session (3-days).
Venue : Inside the Exhibition Halls (no pre-registration necessary.)
*Please note all sessions are conducted only in Japanese.
*Please visit Poster Session area to discuss about presentation.
(Honorifics omitted) Please note that the presenters and programs are subject to change. May. 14[Wed]
In vivo drug screening system and candidate compound for erectile dysfunction
Date:May. 14 (Wed) 12:45 ~ 13:15     Venue: ACA-4
The new develpment of a drug for treatment of non-alcoholic fatty liver disease (NAFLD)
Date:May. 14 (Wed) 12:45 ~ 13:15     Venue: ACA-2
Development of Mini Centrifuge Driven Micro Medical Devices
Date:May. 14 (Wed) 12:45 ~ 13:15     Venue: ACA-7
OCH, an oral drug for multiple sclerosis: Results of first in human study
Date:May. 14 (Wed) 12:45 ~ 13:15     Venue: ACA-3
Cancer stem model cells derived from iPS cells
Date:May. 14 (Wed) 12:45 ~ 13:15     Venue: ACA-1
Catheter-based therapy for carbon monoxide poisoning
Date:May. 14 (Wed) 12:45 ~ 13:15     Venue: ACA-6
Detection of single methylated cytosine using junction-forming DNA probes
Date:May. 14 (Wed) 12:45 ~ 13:15     Venue: ACA-5
Curcumin analog, a new class of tumor angiogenesis inhibitor
Date:May. 14 (Wed) 13:30 ~ 14:00     Venue: ACA-4
Heterogeneous expression pattern of drug-metabolizing enzyme in 3D spheroid of liver cancer cell
Date:May. 14 (Wed) 13:30 ~ 14:00     Venue: ACA-1
Proposal of potential leads for anti-infectious drugs
Date:May. 14 (Wed) 13:30 ~ 14:00     Venue: ACA-2
Drug development for sepsis and MOF through neutrophil regulation
Date:May. 14 (Wed) 13:30 ~ 14:00     Venue: ACA-3
Breakthrough for the prevention, treatment and diagnosis of Alzheimer's disease
Date:May. 14 (Wed) 13:30 ~ 14:00     Venue: ACA-5
New processed goods derived from human hair and evaluation technology using keratin film
Date:May. 14 (Wed) 13:30 ~ 14:00     Venue: ACA-7
Multiscale Design and Processing for Nano/Micro Structured devices for bio and medical application
Date:May. 14 (Wed) 13:30 ~ 14:00     Venue: ACA-6
Development of biomarkers of brain infarction
Date:May. 14 (Wed) 14:15 ~ 14:45     Venue: ACA-4
Quantitative molecular image analysis for computer-aided diagnosis
Date:May. 14 (Wed) 14:15 ~ 14:45     Venue: ACA-5
A novel pain therapeutic strategy targeting brain GPR40, a long chain fatty acid receptor
Date:May. 14 (Wed) 14:15 ~ 14:45     Venue: ACA-2
Diagnosis kit for depression using biomarker-targeted metabolism of monoamine transporter
Date:May. 14 (Wed) 14:15 ~ 14:45     Venue: ACA-7
Development of small antibody fragments to use for basic studies of intracellular protein function
Date:May. 14 (Wed) 14:15 ~ 14:45     Venue: ACA-3
Thunder Light "Xenon Pulsed Therapy" Update and Future
Date:May. 14 (Wed) 14:15 ~ 14:45     Venue: ACA-1
Nano Scale ELSA utilizing ink-jet technology and its automation
Date:May. 14 (Wed) 14:15 ~ 14:45     Venue: ACA-6
The discovery and identification of novel biomarkers of disease related protein
Date:May. 14 (Wed) 15:00 ~ 15:30     Venue: ACA-7
Development of flexible endoscopic devices
Date:May. 14 (Wed) 15:00 ~ 15:30     Venue: ACA-6
Zebrafish-based Drug Discovery Systems
Date:May. 14 (Wed) 15:00 ~ 15:30     Venue: ACA-5
Screening of novel combination treatment for radiation therapy
Date:May. 14 (Wed) 15:00 ~ 15:30     Venue: ACA-1
New bio-marker and anti-cancer agent discovered from human sera.
Date:May. 14 (Wed) 15:00 ~ 15:30     Venue: ACA-3
Chemical synthesis of human relaxin-2: a pregnancy hormone with many medicinal implications
Date:May. 14 (Wed) 15:00 ~ 15:30     Venue: ACA-4
Multifunctional peptide-modified nano-carryer composed of self-aggregated block copolymer
Date:May. 14 (Wed) 15:00 ~ 15:30     Venue: ACA-2
Development of oral Salmonella vaccine
Date:May. 14 (Wed) 15:45 ~ 16:15     Venue: ACA-3
Development of Biologically Active Marine Natural Products as a New Anticancer Seed in Asian Area
Date:May. 14 (Wed) 15:45 ~ 16:15     Venue: ACA-2
Introduction of an integrated system HEALS predicting chemical impacts on human health
Date:May. 14 (Wed) 15:45 ~ 16:15     Venue: ACA-5
Mission of the Drug Discovery Support Network
Date:May. 14 (Wed) 15:45 ~ 16:15     Venue: ACA-4
Development of Neuro-feedback System for Mental Health Care
Date:May. 14 (Wed) 15:45 ~ 16:15     Venue: ACA-6
Metformin-induced reversion of exhausted T cells in tumor microenvironment
Date:May. 14 (Wed) 15:45 ~ 16:15     Venue: ACA-1
Establishment of Tsukuba Human Tissue Biobank Center: Effective utilization of human specimens
Date:May. 14 (Wed) 15:45 ~ 16:15     Venue: ACA-7
Water-Filled Laparo-Endoscopic Surgery (WaFLES) update
Date:May. 14 (Wed) 16:30 ~ 17:00     Venue: ACA-6
Efficient systemic delivery of siRNA and microRNA by sCA for therapy and imaging of solid tumors
Date:May. 14 (Wed) 16:30 ~ 17:00     Venue: ACA-1
Development of probe to detect sugar chain recognition molecules
Date:May. 14 (Wed) 16:30 ~ 17:00     Venue: ACA-4
Action of the NCGG Biobank
Date:May. 14 (Wed) 16:30 ~ 17:00     Venue: ACA-7
Introduction of the National Center Biobank Network Project
Date:May. 14 (Wed) 16:30 ~ 17:00     Venue: ACA-5
Development of nanoparticle vaccine targeting Plasmodium falciparum enolase
Date:May. 14 (Wed) 16:30 ~ 17:00     Venue: ACA-3
(Honorifics omitted) Please note that the presenters and programs are subject to change. May. 15[Thur]
Multiplex Screening system with Coctail PCR and DNA chromatography
Date:May. 15 (Thu) 11:00 ~ 11:30     Venue: ACA-6
Preparation method of multipotent stem cells derived from adipose tissues for regenerative therapy
Date:May. 15 (Thu) 11:00 ~ 11:30     Venue: ACA-3
Acquisition of diagnostic and prognostic markers for cancers using antibody-based proteomics.
Date:May. 15 (Thu) 11:00 ~ 11:30     Venue: ACA-1
Application of human iPS-derived mesodermal cells to drug development
Date:May. 15 (Thu) 11:00 ~ 11:30     Venue: ACA-2
Development of novel protein-based antiviral drugs
Date:May. 15 (Thu) 11:00 ~ 11:30     Venue: ACA-4
Individualization of drug therapy based on pharmacogenomics
Date:May. 15 (Thu) 11:00 ~ 11:30     Venue: ACA-7
Rapid and easy detection methods for fungal beta-glucans
Date:May. 15 (Thu) 11:00 ~ 11:30     Venue: ACA-5
Pathogen detection and identification of Fusarium wilt of strawberry with DNA amplification
Date:May. 15 (Thu) 11:45 ~ 12:15     Venue: ACA-5
Structural studies of Influenza RNA-polymerase for novel drug design
Date:May. 15 (Thu) 11:45 ~ 12:15     Venue: ACA-2
3D cell culture using new type enzyme-treated collagen matrix: application of osteogenesis
Date:May. 15 (Thu) 11:45 ~ 12:15     Venue: ACA-3
Epileptic Seizure Monitoring Device based on Heart Rate Variability Analysis
Date:May. 15 (Thu) 11:45 ~ 12:15     Venue: ACA-6
Novel autoantibodies as biomarkers for interstitial pneumonitis
Date:May. 15 (Thu) 11:45 ~ 12:15     Venue: ACA-7
Development of Novel Photochemical Anti-cancer Agent
Date:May. 15 (Thu) 11:45 ~ 12:15     Venue: ACA-1
Development and evaluation of brain-directed therapeutics for neurodegenerative lysosomal diseases
Date:May. 15 (Thu) 11:45 ~ 12:15     Venue: ACA-4
New prognostic marker for canine mast cell tumors
Date:May. 15 (Thu) 13:15 ~ 13:45     Venue: ACA-6
In silico drug discovery with FAMS and chooseLD
Date:May. 15 (Thu) 13:15 ~ 13:45     Venue: ACA-2
Nuclear receptor-mediated alleviation of alcoholic fatty liver by food polyphenols
Date:May. 15 (Thu) 13:15 ~ 13:45     Venue: ACA-5
Development and application of self-gelatinizable nucleic acid
Date:May. 15 (Thu) 13:15 ~ 13:45     Venue: ACA-1
SNX1 regulates the ligand-stimulated EGFR/MET endocytosis in the gefitinib-resistant NSCLC cells
Date:May. 15 (Thu) 13:15 ~ 13:45     Venue: ACA-4
Collagen vitrigel: A new biomaterial of highly-dense collagen fibrils useful for tissue regeneration
Date:May. 15 (Thu) 13:15 ~ 13:45     Venue: ACA-3
Evaluation method of mitochondrial dysfunction in the biological sample
Date:May. 15 (Thu) 13:15 ~ 13:45     Venue: ACA-7
Cell-model membranes as a new drug discovery technology
Date:May. 15 (Thu) 14:00 ~ 14:30     Venue: ACA-2
Development of a New Transfusion System with in vitro Generated Platelets
Date:May. 15 (Thu) 14:00 ~ 14:30     Venue: ACA-3
A novel diagnostic technology that enables to detect changes and abnormalities in complex mixture
Date:May. 15 (Thu) 14:00 ~ 14:30     Venue: ACA-6
Development of Nobel Fluorescent dye for Biomolecules
Date:May. 15 (Thu) 14:00 ~ 14:30     Venue: ACA-7
Clinical appliocation of bovine leukosis vaccine
Date:May. 15 (Thu) 14:00 ~ 14:30     Venue: ACA-5
Challenge for development of sensorineural hearing impairment as targeting calpain
Date:May. 15 (Thu) 14:00 ~ 14:30     Venue: ACA-4
Treatment of solid tumor with recombinant anaerobacterium
Date:May. 15 (Thu) 14:00 ~ 14:30     Venue: ACA-1
Nano-Cups: Fabrication and Applications of Cup-Shaped Functional Nano-Particles for Cell Biology
Date:May. 15 (Thu) 14:45 ~ 15:15     Venue: ACA-7
High-throughput nanofibers array for controlling human pluripotent stem cells
Date:May. 15 (Thu) 14:45 ~ 15:15     Venue: ACA-3
Application of fish antibodies to diagnoses and drug target
Date:May. 15 (Thu) 14:45 ~ 15:15     Venue: ACA-4
Useful analytical tools for the identification of electron transportee and/or antioxidant
Date:May. 15 (Thu) 14:45 ~ 15:15     Venue: ACA-5
Development of pyrrole-imidazole polyamides targeting for prostate cancer
Date:May. 15 (Thu) 14:45 ~ 15:15     Venue: ACA-1
Labeling Technologies for PET Molecular Imaging of Drugs and Food Ingredients
Date:May. 15 (Thu) 14:45 ~ 15:15     Venue: ACA-2
Nanomaterials, micromachines, sensors and watching systems for medical and nursing purposes
Date:May. 15 (Thu) 14:45 ~ 15:15     Venue: ACA-6
Biodegradable Poly(L-lactide) Filaments Mesh for Regenerative Medicine of Maxillofacial bone
Date:May. 15 (Thu) 15:30 ~ 16:00     Venue: ACA-3
antibacterial biocompatible nanoparticles
Date:May. 15 (Thu) 15:30 ~ 16:00     Venue: ACA-4
identification of novel biomarkers as a potential clinical implication in ovarian cancer
Date:May. 15 (Thu) 15:30 ~ 16:00     Venue: ACA-7
Development of anti-aging compounds based on original mouse models
Date:May. 15 (Thu) 15:30 ~ 16:00     Venue: ACA-2
Life Innovation by use of LED
Date:May. 15 (Thu) 15:30 ~ 16:00     Venue: ACA-6
The significance of exosome in cancer
Date:May. 15 (Thu) 15:30 ~ 16:00     Venue: ACA-1
Photosynthesis and its application of microalgae and cyanobacteria
Date:May. 15 (Thu) 15:30 ~ 16:00     Venue: ACA-5
Development of photo-triggered ultrafast manipulation of DNA and RNA
Date:May. 15 (Thu) 16:15 ~ 16:45     Venue: ACA-7
Anti-cancer drug leads based on the natural scafold
Date:May. 15 (Thu) 16:15 ~ 16:45     Venue: ACA-1
MISSION OF THE DRUG DISCOVERY SUPPORT NETWORK
Date:May. 15 (Thu) 16:15 ~ 16:45     Venue: ACA-4
Crystallization methods for protein and small molecules
Date:May. 15 (Thu) 16:15 ~ 16:45     Venue: ACA-2
Bioabsorbable polymers (BAPs) curing the wound of the organ - Organ reproduction is possible by BAPs
Date:May. 15 (Thu) 16:15 ~ 16:45     Venue: ACA-3
Realizations of Objective Measurement Device of Haptic Softness and Their Expansion to Medical Field
Date:May. 15 (Thu) 16:15 ~ 16:45     Venue: ACA-6
Characterization of bio-active substances acting on health and youth--Longevity Genes and Health--
Date:May. 15 (Thu) 16:15 ~ 16:45     Venue: ACA-5
(Honorifics omitted) Please note that the presenters and programs are subject to change. May. 16[Fri]
The EMARS method to identify clustered molecules with a given molecule on the living cells
Date:May. 16 (Fri) 11:00 ~ 11:30     Venue: ACA-3
The new prediction systems to prevent the fall-down accidents of the dementia patients from the bed
Date:May. 16 (Fri) 11:00 ~ 11:30     Venue: ACA-6
Photoresponsive materials for dynamic control of cellular microenvironments
Date:May. 16 (Fri) 11:00 ~ 11:30     Venue: ACA-5
Development of Novel Anti-metastatic Therapies Targeting Cancer Stem Cells and EMT
Date:May. 16 (Fri) 11:00 ~ 11:30     Venue: ACA-1
RIKEN's activities for drug discovery & medical technology from academia
Date:May. 16 (Fri) 11:00 ~ 11:30     Venue: ACA-4
Preparation of highly cell-compatible biomaterials based on fish-scale collagen
Date:May. 16 (Fri) 11:00 ~ 11:30     Venue: ACA-7
Development of rapid and sensitive methods for the functional evaluation of drug transporters
Date:May. 16 (Fri) 11:00 ~ 11:30     Venue: ACA-2
Artificial Cellular Membrane Chips for Drug Discovery Screening
Date:May. 16 (Fri) 11:45 ~ 12:15     Venue: ACA-2
The advantage of a new tumor associated antigen KK-LC-1 for diagnosis of gastric cancer
Date:May. 16 (Fri) 11:45 ~ 12:15     Venue: ACA-1
Drug eluting coil using liposome.
Date:May. 16 (Fri) 11:45 ~ 12:15     Venue: ACA-6
Top-down proteomic analysis: search for biomakers using FD-LC-MS/MS method
Date:May. 16 (Fri) 11:45 ~ 12:15     Venue: ACA-5
Prevention of non-communicable disease by flavor precursor in garlic
Date:May. 16 (Fri) 11:45 ~ 12:15     Venue: ACA-4
Real-time stress monitoring for fish by using biosensor
Date:May. 16 (Fri) 11:45 ~ 12:15     Venue: ACA-7
High contrast fluorescence imaging using an optical interference mirror slide
Date:May. 16 (Fri) 11:45 ~ 12:15     Venue: ACA-3
AKR1C3 inhibitors as candidates of therapeutic agent for castration-resistant prostate cancer
Date:May. 16 (Fri) 13:15 ~ 13:45     Venue: ACA-1
Rapid Methylation for sp3-hybridized carbon for synthesis of short-lived 11C incorporated PET probes
Date:May. 16 (Fri) 13:15 ~ 13:45     Venue: ACA-3
A Novel Metal-free and Blue-light Controllable Nitric Oxide Releaser Applicable to Tissue Samples
Date:May. 16 (Fri) 13:15 ~ 13:45     Venue: ACA-4
Development of Rechargeable Material produced by using Microorganisms
Date:May. 16 (Fri) 13:15 ~ 13:45     Venue: ACA-7
Estimating virulence site of gene & designing synthetic protein by in silico evolutionary analysis
Date:May. 16 (Fri) 13:15 ~ 13:45     Venue: ACA-5
Development of shRNA library screening system for nucleic acid medicine
Date:May. 16 (Fri) 13:15 ~ 13:45     Venue: ACA-2
Measurement of velopharynx movement using stereoscopic endoscope
Date:May. 16 (Fri) 13:15 ~ 13:45     Venue: ACA-6
New extracorporeal blood purification system with an ultra-small volume circuit for newborn infant
Date:May. 16 (Fri) 14:00 ~ 14:30     Venue: ACA-6
Production and evaluation of crude drug including Glycyrrhiza by hydroponic cultivation system
Date:May. 16 (Fri) 14:00 ~ 14:30     Venue: ACA-4
Development of low cost planar patch clamp system
Date:May. 16 (Fri) 14:00 ~ 14:30     Venue: ACA-2
Regulation of telomere structure by G-quadruplex binding protein
Date:May. 16 (Fri) 14:00 ~ 14:30     Venue: ACA-1
Innovation of NIR luciferin
Date:May. 16 (Fri) 14:00 ~ 14:30     Venue: ACA-3
the biobank of TOHOKU MEDICAL MEGABANK project
Date:May. 16 (Fri) 14:00 ~ 14:30     Venue: ACA-5
Antimicrobial-resistant bacteria in urban watershed
Date:May. 16 (Fri) 14:00 ~ 14:30     Venue: ACA-7
Development of fluorescent probes for selective detection of intracellular Fe(II) ion
Date:May. 16 (Fri) 14:45 ~ 15:15     Venue: ACA-3
Antifungal azoles inhibit the Wnt/beta-catenin signaling
Date:May. 16 (Fri) 14:45 ~ 15:15     Venue: ACA-1
Activity of Rare Disease Bank, National Institute of Biomedical Innovation
Date:May. 16 (Fri) 14:45 ~ 15:15     Venue: ACA-5
Fundamental studies for application development of lecithin organogelators
Date:May. 16 (Fri) 14:45 ~ 15:15     Venue: ACA-7
Terahertz Chemical Microscopy
Date:May. 16 (Fri) 14:45 ~ 15:15     Venue: ACA-6
Mitochondria as a tool for diagnosis and drug evaluation
Date:May. 16 (Fri) 14:45 ~ 15:15     Venue: ACA-2
Aptamer identification using genomic information and development of aptamer-based biosensing assay
Date:May. 16 (Fri) 14:45 ~ 15:15     Venue: ACA-4
CUL3 controls angiogenesis through regulating VEGFR2 mRNA stability
Date:May. 16 (Fri) 15:30 ~ 16:00     Venue: ACA-4
Preclinical research for drug and medical device using MHC-defined CLAWN miniature swine
Date:May. 16 (Fri) 15:30 ~ 16:00     Venue: ACA-6
Regulation of allergic diseases by allergen-specific monoclonal antibody Fab
Date:May. 16 (Fri) 15:30 ~ 16:00     Venue: ACA-2
Applications of high molecular weight silk fibroin to cosmetics
Date:May. 16 (Fri) 15:30 ~ 16:00     Venue: ACA-7
The role of TGF-beta signaling in tumor blood- and lymph- angiogenesis.
Date:May. 16 (Fri) 15:30 ~ 16:00     Venue: ACA-1
Photo-dissociation method of Pathological Materials by using Mid-Infrared Free-Electron Laser
Date:May. 16 (Fri) 15:30 ~ 16:00     Venue: ACA-5
Introduction of ultra-high magnetic field NMR spectrometers with ultra-high sensitivity
Date:May. 16 (Fri) 15:30 ~ 16:00     Venue: ACA-3